DCDaniel Chang

Daniel Chang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daniel Chang has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Under Pressure: Advancing the Diagnosis of Pediatric CSF Leaks with Digital Subtraction Myelography

    by Catherine M. Garcia, Daniel Chang, Marcel M. Maya, Vikram S. Wadhwa, Ravi S. Prasad, Franklin G. Moser, Wouter I. Schievink


  • Future of Endovascular and Surgical Treatments of Atherosclerotic Intracranial Stenosis

    by Theresa A. Elder, Timothy G. White, Henry H. Woo, Adnan H. Siddiqui, Ravi Nunna, Farhan Siddiq, Giuseppe Esposito, Daniel Chang, Nestor R. Gonzalez, Sepideh Amin-Hanjani

    Intracranial atherosclerotic disease and resultant intracranial stenosis is a global leading cause of stroke, and poses an ongoing treatment challenge. Among patients with intracranial stenosis, those with hemodynamic compromise are at high risk for recurrent stroke despite medical therapy and risk factor modification. Revascularization of the hypoperfused territory is the most plausible treatment strategy for these high-risk patients, yet surgical and endovascular therapies have not yet shown to be sufficiently safe and effective in randomized controlled trials. Advances in diagnostic and therapeutic technologies have led to a resurgence of interest in surgical and endovascular treatment strategies, with a growing body of evidence to support their further evaluation in the treatment of select patient populations. This review outlines the current and emerging endovascular and surgical treatments and highlights promising future management strategies.


  • Open Access

    1269. Prospective Evaluation of a Machine Learning Model that Guides Indication for Antibiotics in Lower Respiratory Tract Infections

    by Sarah Tang, Maciej Piotr Chlebicki, Shimin Jasmine Chung, De Zhi Chin, Daniel Chang, Andrea Kwa

    Over-prescribing of antibiotics for suspected acute bacterial lower respiratory tract infections (abLRTI) is prevalent. A classification model that can identify instances when antibiotics should be initiated or withheld was previously developed with promising results (80% accuracy). This, however, was based on a retrospective dataset. We conducted a prospective evaluation of this model in the hospital antimicrobial stewardship unit (ASU) to validate its performance and compare its effectiveness against current ASU strategies. Inpatients audited by the hospital ASU between 10 January and 23 March 2023 (twice weekly) were enrolled into this study. Relevant patient information (e.g., clinical notes, radiology reports, vital signs) was extracted from our hospital’s electronic data repository for model inference. The presence of abLRTI as determined by the model, the patient’s primary care team and ASU review were compared. Cases that saw differing opinions between any of the three operators were subsequently reviewed by an independent Infectious Diseases physician, who provided the ground truth for that case. A total of 851 cases were included, of which 235 (27.6%) had true abLRTI. The model was most accurate in determining the presence versus absence of abLRTI (734/851, 86.3%), while ASU review and primary care team were correct in only 698 (82.0%) and 677 (79.6%) cases respectively. Primary care team demonstrated greatest sensitivity in the suspicion for abLRTI (91.9%); unfortunately, it also over-diagnosed abLRTI in 155 (42%) patients. Among these false-positive cases, the model rightly rejected presence of abLRTI in 126 (81.3%) patients whereas only 66 (64.1%) of them were identified by ASU. ASU outperformed the model in having a lower false-negative rate when abLRTI is suspected (17.3% vs. 22.0%). The model displayed consistent performance in a prospective cohort. Findings support its value in guiding decisions on antibiotic initiation for suspected abLRTI. Deploying this model to augment current ASU capabilities should be strongly considered. All Authors: No reported disclosures

  • Surgical Management of Intracranial Atherosclerotic Disease

    by Miguel D. Quintero-Consuegra, Daniel Chang, Peyton Nisson, Nestor R. Gonzalez

  • Transvenous Pressure Monitoring Guides Endovascular Treatment of Vein of Galen Malformation: A Technical Note

    by Daniel Chang, Robin Babadjouni, Peyton Nisson, Julie Lynn Chan, Miguel Quintero-Consuegra, Juan Felipe Toscano, Nestor Raul Gonzalez

    Introduction: Vein of Galen malformations (VGMs) are complex congenital arteriovenous malformations that generally require serial endovascular treatment sessions to slowly correct the high-flow fistulous connections that cause increased venous pressures and ultimately lead to the classic presentations of heart failure, hydrocephalus, and intracranial hemorrhages. Despite the advances in endovascular technology and embolic materials, the resolution of embolization is often limited to the subjective view of diminished flow on angiograms. Case Report: An 8-month-old patient with a VGM developed clinical signs of heart failure and growing head circumference with ventriculomegaly. The patient was treated endovascularly with a transvenous approach for coil embolization while undergoing continuous monitoring of the post-malformation venous pressures. The arterial and venous systolic blood pressures (SBP) were collected at serial time points and used to measure estimated 95% confidence interval bounds for arteriovenous SBP gradients and determine when sufficient coil embolization and flow reduction was thought to be achieved. Conclusion: The transvenous pressure monitoring demonstrated progressively increasing pressure gradients between the arterial and venous systems that correlated with the degree of flow reduction on angiographic runs. The patient underwent successful coil embolization of the VGM and had improvement of heart failure and ventricular size in follow-up at 8-month post-op. This provides a novel technique to introduce an objective measurement that can guide the embolization of a VGM.


  • Open Access

    A Breast Cancer Survivor’s Self-Controlled Case Report: Methylprednisolone Acetate Provided a Week Longer Analgesia Than Dexamethasone Sodium Phosphate via Thoracic Paravertebral Blockade

    by Jinlei Li, Kay Lee, Daniel Chang, Praba Boominathan, Trevor Banack

    Proper perioperative pain control with opioid-sparing techniques that extend into post-discharge arena is desirable yet hard to accomplish in breast cancer patients. We here reported a case where we took advantage of long-acting local anesthetics in conjunction with glucocorticoids of different hydrophilic/lipophilic properties and achieved prolonged analgesia for days after single administration thoracic paravertebral blockade. Further exploration into the potential effects of long-acting glucocorticoids in breast cancer patients through peripheral nerve blockage is warranted.